10 20 30 40 50 60 70 80 2IMA - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 04-OCT-06 2IMA
TITLE CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN TITLE 2 INHIBITED BY 2,4-DICHLOROCINNAMIC HYDROXAMATE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: BOTULINUM NEUROTOXIN A LIGHT-CHAIN; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.24.69; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CLOSTRIDIUM BOTULINUM; SOURCE 3 ORGANISM_TAXID: 1491; SOURCE 4 GENE: BOTA, ATX, BNA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL-21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-15B
KEYWDS CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A, PROTEASE KEYWDS 2 INHIBITORS, SUBSTRATE SPECIFICITY, SUBSTRATE SWITCHING, KEYWDS 3 HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR N.R.SILVAGGI,K.N.ALLEN
REVDAT 2 24-FEB-09 2IMA 1 VERSN REVDAT 1 05-JUN-07 2IMA 0
JRNL AUTH N.R.SILVAGGI,G.E.BOLDT,M.S.HIXON,J.P.KENNEDY, JRNL AUTH 2 S.TZIPORI,K.D.JANDA,K.N.ALLEN JRNL TITL STRUCTURES OF CLOSTRIDIUM BOTULINUM NEUROTOXIN JRNL TITL 2 SEROTYPE A LIGHT CHAIN COMPLEXED WITH JRNL TITL 3 SMALL-MOLECULE INHIBITORS HIGHLIGHT ACTIVE-SITE JRNL TITL 4 FLEXIBILITY. JRNL REF CHEM.BIOL. V. 14 533 2007 JRNL REFN ISSN 1074-5521 JRNL PMID 17524984 JRNL DOI 10.1016/J.CHEMBIOL.2007.03.014
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 3 NUMBER OF REFLECTIONS : 60589 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3232 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.94 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.99 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4599 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.47 REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE SET COUNT : 261 REMARK 3 BIN FREE R VALUE : 0.3010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6516 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 464 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.38000 REMARK 3 B22 (A**2) : 0.72000 REMARK 3 B33 (A**2) : 0.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.90000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.177 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.163 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.119 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.884 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6690 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4563 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9033 ; 1.456 ; 1.958 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11112 ; 0.888 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 794 ; 9.220 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 331 ;37.656 ;24.683 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1159 ;14.072 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;15.271 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 981 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7383 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1407 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1371 ; 0.210 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 4683 ; 0.194 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3319 ; 0.187 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 3403 ; 0.088 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 431 ; 0.157 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 5 ; 0.092 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 17 ; 0.263 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 42 ; 0.170 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 11 ; 0.312 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5174 ; 0.988 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1626 ; 0.197 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 6479 ; 1.158 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3232 ; 1.896 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2554 ; 2.617 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS
REMARK 4 REMARK 4 2IMA COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-OCT-06. REMARK 100 THE RCSB ID CODE IS RCSB039744.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-FEB-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X12B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63852 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.940 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.01 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.57800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10-15% PEG 2000 MME, 0.3M (NH4) REMARK 280 2HPO4, 0.05M TRIS, PH 8.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298.0K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.62850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS A DIMER, BUT THE ENZYME IS REMARK 300 BIOLOGICALLY ACTIVE AS A MONOMER.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 ASN A 26 REMARK 465 VAL A 27 REMARK 465 GLY A 28 REMARK 465 GLN A 29 REMARK 465 PRO A 63 REMARK 465 GLU A 64 REMARK 465 ALA A 65 REMARK 465 LYS A 66 REMARK 465 GLN A 67 REMARK 465 VAL A 202 REMARK 465 ASP A 203 REMARK 465 THR A 204 REMARK 465 VAL A 245 REMARK 465 ASN A 246 REMARK 465 THR A 247 REMARK 465 ASN A 248 REMARK 465 ALA A 249 REMARK 465 TYR A 250 REMARK 465 TYR A 251 REMARK 465 GLU A 252 REMARK 465 MET A 253 REMARK 465 SER A 254 REMARK 465 GLY A 255 REMARK 465 LEU A 256 REMARK 465 THR A 306 REMARK 465 THR A 307 REMARK 465 PHE A 419 REMARK 465 THR A 420 REMARK 465 GLY A 421 REMARK 465 LEU A 422 REMARK 465 PHE A 423 REMARK 465 GLU A 424 REMARK 465 MET B -19 REMARK 465 GLY B -18 REMARK 465 SER B -17 REMARK 465 SER B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 VAL B 27 REMARK 465 GLY B 28 REMARK 465 PRO B 63 REMARK 465 GLU B 64 REMARK 465 ALA B 65 REMARK 465 LYS B 66 REMARK 465 GLN B 67 REMARK 465 VAL B 68 REMARK 465 PRO B 69 REMARK 465 LYS B 244 REMARK 465 VAL B 245 REMARK 465 ASN B 246 REMARK 465 THR B 247 REMARK 465 ASN B 248 REMARK 465 ALA B 249 REMARK 465 TYR B 250 REMARK 465 TYR B 251 REMARK 465 GLU B 252 REMARK 465 MET B 253 REMARK 465 SER B 254 REMARK 465 GLY B 255 REMARK 465 LEU B 256 REMARK 465 THR B 306 REMARK 465 LYS B 417 REMARK 465 ASN B 418 REMARK 465 PHE B 419 REMARK 465 THR B 420 REMARK 465 GLY B 421 REMARK 465 LEU B 422 REMARK 465 PHE B 423 REMARK 465 GLU B 424
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 70 CG1 CG2 REMARK 470 ASN B 26 CB CG OD1 ND2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 113 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 ARG A 113 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 ASP B 370 N - CA - C ANGL. DEV. = 19.9 DEGREES REMARK 500 LYS B 371 N - CA - C ANGL. DEV. = -25.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 157 -147.49 -86.74 REMARK 500 ASN A 409 46.12 -89.67 REMARK 500 VAL B 17 -72.08 -112.77 REMARK 500 PRO B 25 54.42 -67.77 REMARK 500 SER B 157 -148.13 -84.18 REMARK 500 VAL B 202 66.46 167.19 REMARK 500 ASN B 205 91.59 -166.03 REMARK 500 ALA B 271 9.71 -68.09 REMARK 500 ASP B 370 163.82 -37.61 REMARK 500 LYS B 371 40.61 -149.44 REMARK 500 ASN B 409 43.08 -99.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU B 201 VAL B 202 -107.00 REMARK 500 PHE B 369 ASP B 370 107.11 REMARK 500 ASP B 370 LYS B 371 -111.90 REMARK 500 REMARK 500 REMARK: NULL
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 500 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 223 NE2 REMARK 620 2 GLU A 262 OE1 103.0 REMARK 620 3 GLU A 262 OE2 157.3 55.4 REMARK 620 4 GB4 A 600 O12 93.4 92.1 81.6 REMARK 620 5 GB4 A 600 O14 110.9 142.2 88.3 70.1 REMARK 620 6 HIS A 227 NE2 94.3 98.5 95.8 165.1 95.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 500 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 227 NE2 REMARK 620 2 GLU B 262 OE1 92.7 REMARK 620 3 GLU B 262 OE2 97.2 54.9 REMARK 620 4 GB4 B 600 O14 102.0 86.6 137.7 REMARK 620 5 GB4 B 600 O12 167.0 79.3 86.7 67.6 REMARK 620 6 HIS B 223 NE2 103.5 154.8 103.3 108.3 87.6 REMARK 620 N 1 2 3 4 5
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 500 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 500 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GB4 A 600 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GB4 B 600
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2ILP RELATED DB: PDB REMARK 900 CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN REMARK 900 INHIBITED BY 4-CHLOROCINNAMIC HYDROXAMATE REMARK 900 RELATED ID: 2IMB RELATED DB: PDB REMARK 900 CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN REMARK 900 INHIBITED BY L-ARGININE HYDROXAMATE REMARK 900 RELATED ID: 2IMC RELATED DB: PDB REMARK 900 CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN, REMARK 900 RESIDUES 1-424
DBREF 2IMA A 1 424 UNP Q7B8V4 Q7B8V4_CLOBO 1 424 DBREF 2IMA B 1 424 UNP Q7B8V4 Q7B8V4_CLOBO 1 424
SEQADV 2IMA MET A -19 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA GLY A -18 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA SER A -17 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA SER A -16 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS A -15 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS A -14 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS A -13 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS A -12 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS A -11 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS A -10 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA SER A -9 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA SER A -8 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA GLY A -7 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA LEU A -6 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA VAL A -5 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA PRO A -4 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA ARG A -3 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA GLY A -2 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA SER A -1 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS A 0 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA GLN A 2 UNP Q7B8V4 PRO 2 CONFLICT SEQADV 2IMA MET B -19 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA GLY B -18 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA SER B -17 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA SER B -16 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS B -15 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS B -14 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS B -13 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS B -12 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS B -11 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS B -10 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA SER B -9 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA SER B -8 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA GLY B -7 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA LEU B -6 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA VAL B -5 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA PRO B -4 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA ARG B -3 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA GLY B -2 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA SER B -1 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA HIS B 0 UNP Q7B8V4 CLONING ARTIFACT SEQADV 2IMA GLN B 2 UNP Q7B8V4 PRO 2 CONFLICT
SEQRES 1 A 444 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 444 LEU VAL PRO ARG GLY SER HIS MET GLN PHE VAL ASN LYS SEQRES 3 A 444 GLN PHE ASN TYR LYS ASP PRO VAL ASN GLY VAL ASP ILE SEQRES 4 A 444 ALA TYR ILE LYS ILE PRO ASN VAL GLY GLN MET GLN PRO SEQRES 5 A 444 VAL LYS ALA PHE LYS ILE HIS ASN LYS ILE TRP VAL ILE SEQRES 6 A 444 PRO GLU ARG ASP THR PHE THR ASN PRO GLU GLU GLY ASP SEQRES 7 A 444 LEU ASN PRO PRO PRO GLU ALA LYS GLN VAL PRO VAL SER SEQRES 8 A 444 TYR TYR ASP SER THR TYR LEU SER THR ASP ASN GLU LYS SEQRES 9 A 444 ASP ASN TYR LEU LYS GLY VAL THR LYS LEU PHE GLU ARG SEQRES 10 A 444 ILE TYR SER THR ASP LEU GLY ARG MET LEU LEU THR SER SEQRES 11 A 444 ILE VAL ARG GLY ILE PRO PHE TRP GLY GLY SER THR ILE SEQRES 12 A 444 ASP THR GLU LEU LYS VAL ILE ASP THR ASN CYS ILE ASN SEQRES 13 A 444 VAL ILE GLN PRO ASP GLY SER TYR ARG SER GLU GLU LEU SEQRES 14 A 444 ASN LEU VAL ILE ILE GLY PRO SER ALA ASP ILE ILE GLN SEQRES 15 A 444 PHE GLU CYS LYS SER PHE GLY HIS GLU VAL LEU ASN LEU SEQRES 16 A 444 THR ARG ASN GLY TYR GLY SER THR GLN TYR ILE ARG PHE SEQRES 17 A 444 SER PRO ASP PHE THR PHE GLY PHE GLU GLU SER LEU GLU SEQRES 18 A 444 VAL ASP THR ASN PRO LEU LEU GLY ALA GLY LYS PHE ALA SEQRES 19 A 444 THR ASP PRO ALA VAL THR LEU ALA HIS GLU LEU ILE HIS SEQRES 20 A 444 ALA GLY HIS ARG LEU TYR GLY ILE ALA ILE ASN PRO ASN SEQRES 21 A 444 ARG VAL PHE LYS VAL ASN THR ASN ALA TYR TYR GLU MET SEQRES 22 A 444 SER GLY LEU GLU VAL SER PHE GLU GLU LEU ARG THR PHE SEQRES 23 A 444 GLY GLY HIS ASP ALA LYS PHE ILE ASP SER LEU GLN GLU SEQRES 24 A 444 ASN GLU PHE ARG LEU TYR TYR TYR ASN LYS PHE LYS ASP SEQRES 25 A 444 ILE ALA SER THR LEU ASN LYS ALA LYS SER ILE VAL GLY SEQRES 26 A 444 THR THR ALA SER LEU GLN TYR MET LYS ASN VAL PHE LYS SEQRES 27 A 444 GLU LYS TYR LEU LEU SER GLU ASP THR SER GLY LYS PHE SEQRES 28 A 444 SER VAL ASP LYS LEU LYS PHE ASP LYS LEU TYR LYS MET SEQRES 29 A 444 LEU THR GLU ILE TYR THR GLU ASP ASN PHE VAL LYS PHE SEQRES 30 A 444 PHE LYS VAL LEU ASN ARG LYS THR TYR LEU ASN PHE ASP SEQRES 31 A 444 LYS ALA VAL PHE LYS ILE ASN ILE VAL PRO LYS VAL ASN SEQRES 32 A 444 TYR THR ILE TYR ASP GLY PHE ASN LEU ARG ASN THR ASN SEQRES 33 A 444 LEU ALA ALA ASN PHE ASN GLY GLN ASN THR GLU ILE ASN SEQRES 34 A 444 ASN MET ASN PHE THR LYS LEU LYS ASN PHE THR GLY LEU SEQRES 35 A 444 PHE GLU SEQRES 1 B 444 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 444 LEU VAL PRO ARG GLY SER HIS MET GLN PHE VAL ASN LYS SEQRES 3 B 444 GLN PHE ASN TYR LYS ASP PRO VAL ASN GLY VAL ASP ILE SEQRES 4 B 444 ALA TYR ILE LYS ILE PRO ASN VAL GLY GLN MET GLN PRO SEQRES 5 B 444 VAL LYS ALA PHE LYS ILE HIS ASN LYS ILE TRP VAL ILE SEQRES 6 B 444 PRO GLU ARG ASP THR PHE THR ASN PRO GLU GLU GLY ASP SEQRES 7 B 444 LEU ASN PRO PRO PRO GLU ALA LYS GLN VAL PRO VAL SER SEQRES 8 B 444 TYR TYR ASP SER THR TYR LEU SER THR ASP ASN GLU LYS SEQRES 9 B 444 ASP ASN TYR LEU LYS GLY VAL THR LYS LEU PHE GLU ARG SEQRES 10 B 444 ILE TYR SER THR ASP LEU GLY ARG MET LEU LEU THR SER SEQRES 11 B 444 ILE VAL ARG GLY ILE PRO PHE TRP GLY GLY SER THR ILE SEQRES 12 B 444 ASP THR GLU LEU LYS VAL ILE ASP THR ASN CYS ILE ASN SEQRES 13 B 444 VAL ILE GLN PRO ASP GLY SER TYR ARG SER GLU GLU LEU SEQRES 14 B 444 ASN LEU VAL ILE ILE GLY PRO SER ALA ASP ILE ILE GLN SEQRES 15 B 444 PHE GLU CYS LYS SER PHE GLY HIS GLU VAL LEU ASN LEU SEQRES 16 B 444 THR ARG ASN GLY TYR GLY SER THR GLN TYR ILE ARG PHE SEQRES 17 B 444 SER PRO ASP PHE THR PHE GLY PHE GLU GLU SER LEU GLU SEQRES 18 B 444 VAL ASP THR ASN PRO LEU LEU GLY ALA GLY LYS PHE ALA SEQRES 19 B 444 THR ASP PRO ALA VAL THR LEU ALA HIS GLU LEU ILE HIS SEQRES 20 B 444 ALA GLY HIS ARG LEU TYR GLY ILE ALA ILE ASN PRO ASN SEQRES 21 B 444 ARG VAL PHE LYS VAL ASN THR ASN ALA TYR TYR GLU MET SEQRES 22 B 444 SER GLY LEU GLU VAL SER PHE GLU GLU LEU ARG THR PHE SEQRES 23 B 444 GLY GLY HIS ASP ALA LYS PHE ILE ASP SER LEU GLN GLU SEQRES 24 B 444 ASN GLU PHE ARG LEU TYR TYR TYR ASN LYS PHE LYS ASP SEQRES 25 B 444 ILE ALA SER THR LEU ASN LYS ALA LYS SER ILE VAL GLY SEQRES 26 B 444 THR THR ALA SER LEU GLN TYR MET LYS ASN VAL PHE LYS SEQRES 27 B 444 GLU LYS TYR LEU LEU SER GLU ASP THR SER GLY LYS PHE SEQRES 28 B 444 SER VAL ASP LYS LEU LYS PHE ASP LYS LEU TYR LYS MET SEQRES 29 B 444 LEU THR GLU ILE TYR THR GLU ASP ASN PHE VAL LYS PHE SEQRES 30 B 444 PHE LYS VAL LEU ASN ARG LYS THR TYR LEU ASN PHE ASP SEQRES 31 B 444 LYS ALA VAL PHE LYS ILE ASN ILE VAL PRO LYS VAL ASN SEQRES 32 B 444 TYR THR ILE TYR ASP GLY PHE ASN LEU ARG ASN THR ASN SEQRES 33 B 444 LEU ALA ALA ASN PHE ASN GLY GLN ASN THR GLU ILE ASN SEQRES 34 B 444 ASN MET ASN PHE THR LYS LEU LYS ASN PHE THR GLY LEU SEQRES 35 B 444 PHE GLU
HET ZN A 500 1 HET ZN B 500 1 HET GB4 A 600 14 HET GB4 B 600 14
HETNAM ZN ZINC ION HETNAM GB4 (2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE
HETSYN GB4 2,4-DICHLOROCINNAMYLHYDROXAMATE
FORMUL 3 ZN 2(ZN 2+) FORMUL 5 GB4 2(C9 H7 CL2 N O2) FORMUL 7 HOH *464(H2 O)
HELIX 1 1 THR A 80 SER A 100 1 21 HELIX 2 2 THR A 101 GLY A 114 1 14 HELIX 3 3 ILE A 130 THR A 132 5 3 HELIX 4 4 ASP A 216 TYR A 233 1 18 HELIX 5 5 PHE A 260 GLY A 267 1 8 HELIX 6 6 HIS A 269 ILE A 274 5 6 HELIX 7 7 ASP A 275 ALA A 300 1 26 HELIX 8 8 SER A 309 LEU A 322 1 14 HELIX 9 9 ASP A 334 GLU A 347 1 14 HELIX 10 10 THR A 350 LYS A 359 1 10 HELIX 11 11 THR A 395 ALA A 399 5 5 HELIX 12 12 ASN A 409 PHE A 413 5 5 HELIX 13 13 THR B 80 SER B 100 1 21 HELIX 14 14 THR B 101 GLY B 114 1 14 HELIX 15 15 ILE B 130 THR B 132 5 3 HELIX 16 16 ASN B 205 GLY B 209 5 5 HELIX 17 17 ASP B 216 TYR B 233 1 18 HELIX 18 18 SER B 259 GLY B 267 1 9 HELIX 19 19 GLY B 268 PHE B 273 5 6 HELIX 20 20 ASP B 275 ALA B 300 1 26 HELIX 21 21 SER B 309 LEU B 322 1 14 HELIX 22 22 ASP B 334 ILE B 348 1 15 HELIX 23 23 THR B 350 LYS B 359 1 10 HELIX 24 24 PHE B 401 ASN B 405 5 5 HELIX 25 25 ASN B 409 PHE B 413 5 5
SHEET 1 A 8 TYR A 144 GLU A 148 0 SHEET 2 A 8 CYS A 134 ILE A 138 -1 N VAL A 137 O ARG A 145 SHEET 3 A 8 ILE A 19 LYS A 23 -1 N LYS A 23 O ASN A 136 SHEET 4 A 8 VAL A 33 HIS A 39 -1 O ALA A 35 N ALA A 20 SHEET 5 A 8 ILE A 42 ARG A 48 -1 O VAL A 44 N PHE A 36 SHEET 6 A 8 LEU A 151 GLY A 155 1 O ILE A 153 N ILE A 45 SHEET 7 A 8 GLN A 184 ARG A 187 1 O ILE A 186 N ILE A 154 SHEET 8 A 8 GLU A 164 LYS A 166 -1 N LYS A 166 O TYR A 185 SHEET 1 B 2 GLU A 126 LEU A 127 0 SHEET 2 B 2 SER A 302 ILE A 303 1 O SER A 302 N LEU A 127 SHEET 1 C 4 GLY A 211 ALA A 214 0 SHEET 2 C 4 PHE A 192 GLU A 198 -1 N GLU A 198 O GLY A 211 SHEET 3 C 4 VAL A 373 LYS A 375 -1 O PHE A 374 N THR A 193 SHEET 4 C 4 THR A 414 LEU A 416 -1 O LEU A 416 N VAL A 373 SHEET 1 D 2 VAL A 242 PHE A 243 0 SHEET 2 D 2 VAL A 258 SER A 259 -1 O VAL A 258 N PHE A 243 SHEET 1 E 2 SER A 324 GLU A 325 0 SHEET 2 E 2 PHE A 331 SER A 332 -1 O SER A 332 N SER A 324 SHEET 1 F 8 TYR B 144 GLU B 148 0 SHEET 2 F 8 CYS B 134 ILE B 138 -1 N ILE B 135 O GLU B 147 SHEET 3 F 8 ILE B 19 LYS B 23 -1 N TYR B 21 O ILE B 138 SHEET 4 F 8 VAL B 33 HIS B 39 -1 O ALA B 35 N ALA B 20 SHEET 5 F 8 ILE B 42 ARG B 48 -1 O VAL B 44 N PHE B 36 SHEET 6 F 8 LEU B 151 GLY B 155 1 O ILE B 153 N ILE B 45 SHEET 7 F 8 GLN B 184 ARG B 187 1 O ILE B 186 N VAL B 152 SHEET 8 F 8 GLU B 164 LYS B 166 -1 N LYS B 166 O TYR B 185 SHEET 1 G 2 GLU B 126 LEU B 127 0 SHEET 2 G 2 SER B 302 ILE B 303 1 O SER B 302 N LEU B 127 SHEET 1 H 4 LYS B 212 ALA B 214 0 SHEET 2 H 4 PHE B 192 GLU B 197 -1 N PHE B 196 O PHE B 213 SHEET 3 H 4 VAL B 373 LYS B 375 -1 O PHE B 374 N THR B 193 SHEET 4 H 4 THR B 414 LYS B 415 -1 O THR B 414 N LYS B 375 SHEET 1 I 2 SER B 324 GLU B 325 0 SHEET 2 I 2 PHE B 331 SER B 332 -1 O SER B 332 N SER B 324
LINK ZN ZN A 500 NE2 HIS A 223 1555 1555 1.97 LINK ZN ZN A 500 OE1 GLU A 262 1555 1555 1.88 LINK ZN ZN A 500 OE2 GLU A 262 1555 1555 2.59 LINK ZN ZN A 500 O12 GB4 A 600 1555 1555 2.45 LINK ZN ZN A 500 O14 GB4 A 600 1555 1555 2.11 LINK ZN ZN A 500 NE2 HIS A 227 1555 1555 2.11 LINK ZN ZN B 500 NE2 HIS B 227 1555 1555 2.12 LINK ZN ZN B 500 OE1 GLU B 262 1555 1555 2.61 LINK ZN ZN B 500 OE2 GLU B 262 1555 1555 1.93 LINK ZN ZN B 500 O14 GB4 B 600 1555 1555 1.97 LINK ZN ZN B 500 O12 GB4 B 600 1555 1555 2.68 LINK ZN ZN B 500 NE2 HIS B 223 1555 1555 2.01
SITE 1 AC1 4 HIS A 223 HIS A 227 GLU A 262 GB4 A 600 SITE 1 AC2 4 HIS B 223 HIS B 227 GLU B 262 GB4 B 600 SITE 1 AC3 12 ILE A 161 PHE A 163 PHE A 194 HIS A 223 SITE 2 AC3 12 GLU A 224 HIS A 227 GLU A 262 ARG A 363 SITE 3 AC3 12 TYR A 366 PHE A 369 ZN A 500 HOH A1405 SITE 1 AC4 12 VAL B 70 ILE B 161 PHE B 163 PHE B 194 SITE 2 AC4 12 HIS B 223 GLU B 224 HIS B 227 GLU B 262 SITE 3 AC4 12 ARG B 363 TYR B 366 PHE B 369 ZN B 500
CRYST1 73.445 67.257 98.194 90.00 106.53 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.013616 0.000000 0.004041 0.00000
SCALE2 0.000000 0.014868 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010623 0.00000